1. Home
  2. SNTI
  3. SNTI News

Latest Senti Biosciences Inc. (SNTI) News on November 25, 2025

Senti Bio Reports Third Quarter 2025 Financial Results and Confirms Next Clinical Data Readout for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) at the American Society of Hematology Annual Meeting in December

GlobeNewswire

12 days ago

Senti Bio Reports Third Quarter 2025 Financial Results and Confirms Next Clinical Data Readout for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) at the American Society of Hematology Annual Meeting in December

MT Newswires

7 months ago

Top Midday Decliners

MT Newswires

a year ago

Top Midday Gainers

Share on Social Networks: